Vanguard Group’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.98M | Sell |
|
|||||
|
2025
Q1 | $10.9M | Sell |
|
|||||
|
2024
Q4 | $18.2M | Buy |
|
|||||
|
2024
Q3 | $18.6M | Buy |
|
|||||
|
2024
Q2 | $24M | Sell |
|
|||||
|
2024
Q1 | $30.1M | Buy |
|
|||||
|
2023
Q4 | $21.4M | Buy |
|
|||||
|
2023
Q3 | $19.2M | Buy |
|
|||||
|
2023
Q2 | $28.3M | Buy |
|
|||||
|
2023
Q1 | $15.1M | Buy |
|
|||||
|
2022
Q4 | $11.9M | Buy |
|
|||||
|
2022
Q3 | $11.2M | Sell |
|
|||||
|
2022
Q2 | $11.8M | Buy |
|
|||||
|
2022
Q1 | $14.7M | Sell |
|
|||||
|
2021
Q4 | $5.62M | Sell |
|
|||||
|
2021
Q3 | $5.69M | Sell |
|
|||||
|
2021
Q2 | $8.96M | Sell |
|
|||||
|
2021
Q1 | $11.6M | Buy |
|
|||||
|
2020
Q4 | $17.3M | Buy |
|
|||||
|
2020
Q3 | $24M | Sell |
|
|||||
|
2020
Q2 | $28.7M | Sell |
|
|||||
|
2020
Q1 | $21.3M | Buy |
|
|||||
|
2019
Q4 | $29.2M | Buy |
|
|||||
|
2019
Q3 | $30.4M | Buy |
|
|||||
|
2019
Q2 | $42.8M | Buy |
|
|||||
|
2019
Q1 | $26.6M | Buy |
|
|||||
|
2018
Q4 | $13M | Buy |
|
|||||
|
2018
Q3 | $22.6M | Buy |
|
|||||
|
2018
Q2 | $21.2M | Buy |
|
|||||
|
2018
Q1 | $17.8M | Sell |
|
|||||
|
2017
Q4 | $15.8M | Buy |
|
|||||
|
2017
Q3 | $14.4M | Buy |
|
|||||
|
2017
Q2 | $3.86M | Buy |
|
|||||
|
2017
Q1 | $5.53M | Buy |
|
|||||
|
2016
Q4 | $4.87M | Buy |
|
|||||
|
2016
Q3 | $4.16M | Buy |
|
|||||
|
2016
Q2 | $3.44M | Buy |
|
|||||
|
2016
Q1 | $172K | Buy |
|
|||||
|
2015
Q4 | $394K | Buy |
|